Apex Hospitals, Malviya Nagar Inaugurates FibroScan Services for Advanced Liver Diagnostics

Apex Hospitals, Malviya Nagar, has taken a significant step forward in liver care with the inauguration of FibroScan services, a state-of-the-art, non-invasive diagnostic technology for assessing liver health. The service was inaugurated by Dr. S. B. Jhawar, Chairman, Apex Hospitals, in the presence of Dr. Mohammad Rehan and Dr. Ashok Kumar Dudhwal, both Consultants in the Department of Gastroenterology. The launch marks an important addition to the hospital's growing portfolio of advanced diagnostic capabilities.

FibroScan is an FDA-approved technology that measures liver scarring (fibrosis) caused by a range of liver diseases, quickly, painlessly, and without the need for surgery. Similar in procedure to a conventional liver ultrasound, it is performed on an outpatient basis and provides a reliable, non-surgical alternative to the traditional liver biopsy. The technology is particularly valuable for detecting liver fibrosis and cirrhosis, assessing fatty liver disease, monitoring liver damage caused by hepatitis and metabolic disorders, and supporting early diagnosis and treatment planning. By enabling clinicians to assess the extent of liver damage without invasive procedures, FibroScan allows for faster, more accurate clinical decision-making and a significantly better experience for patients.

The introduction of FibroScan at Apex Hospitals, Malviya Nagar, reflects the hospital's ongoing commitment to bringing advanced diagnostics and specialized care closer to the community. With over 30 years of medical excellence and a strong focus on gastroenterology and digestive wellness, Apex Hospitals continues to invest in technologies that support early detection, better outcomes, and accessible healthcare for all.